1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Human |
Cat.No | ABC-X0013C |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Transfected Stable Cell Lines |
Size/Quantity | 1 vial |
Cell Type | Lymphocytes |
Shipping Info | Dry Ice |
Growth Conditions | 37 °C, 5% CO2 |
Source Organ | Lymphatic |
Disease | Normal |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Overexpression Stable Cell Lines |
Host Cell | BAF3 |
The EML4 ALK (F1174L) BAF3 Cell Line is constructed by lentiviral-mediated stable integration of human EML4-ALK fusion carrying the F1174L activating mutation into BAF3 cells. This mutation occurs within the ALK kinase domain and contributes to increased oncogenicity and reduced inhibitor binding. Stable clones are maintained under antibiotic selection and confirmed by qRT-PCR.
Target
EML4-ALK is a constitutively active fusion protein in non-small cell lung cancer (NSCLC). The F1174L mutation enhances kinase activity and induces resistance to ALK inhibitors such as crizotinib. This model is suitable for studying ALK-driven oncogenesis and resistance mechanisms. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.
For research use only